Combining AFM13, a bispecific CD30/CD16 antibody, with cytokine-activated cord blood-derived NK cells facilitates CAR-like responses against CD30+ malignancies Purpose: Natural killer (NK) cell recognition and function against NK-resistant cancers remains substantial barriers to the broad application of NK cell…
Tumor necrosis factor, cachexin TNF-α cytokine NFKB
Tregs, B, NK cells: TNF-α, TNF-β, LT-α, LT-β, TNFR, NF-κB